Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: Krishnacreations fotolia

    Novel mechanism in herpesvirus-induced malignancies

    Kaposi’s sarcoma-associated herpesvirus was found to dysregulate the Wnt/beta-catenin pathway within endothelial cells, which might be a novel mechanism in herpesvirus-induced malignancies.

    Virology Journal 2014, 11:218
  • Ovarian cancer driver

    A combined analysis of immunohistochemical and genomic data for ovarian cancer reveals that PTEN loss is a common and prognostic driver event

    Genome Biology 2014, 15:526
  • Image attributed to: From wikimedia commons, by James Heilman, MD - CC-3

    MicroRNAs in prostate cancer

    Benjamin Jackson and colleagues review our current understanding of the functional consequences of microRNA dysregulation in the development of prostate cancer, and the identification of potential microRNA targets as serum biomarkers.

    BMC Cancer 2014, 14:930
  • Functions of lncRNA HOTAIR in lung cancer

    Loewen et al. discuss how exploiting the role of long noncoding RNA HOTAIR in proliferation, survival, invasion, metastasis, and drug resistance in lung cancer cells could potentially diagnose and treat lung cancer.

    Journal of Hematology & Oncology 2014, 7:90
  • Overestimation of methylation

    Previous reports of DNA hypermethylation in patients may be overestimated as a consequence of the use of non-quantitative methodology.

    Clinical Epigenetics 2014, 6:22

AuthorMapper

Authors of BioMed Central cancer-related articles, by location

Powered by AuthorMapper.com

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.

ez-reprint

Author profile

Wei Zhang

Director, Cancer Genomics Core Lab, University of Texas